Figures and data

Accessible-volume (AV) simulations of LD fluorophores on TmrAB variants.
AV simulations were performed for LD555 (donor) and LD655 (acceptor) fluorophores attached to the selected TmrAB labeling sites to assess whether donor-acceptor distances are suitable for smFRET measurements30. a, TmrABNBD (TmrAC416BL458C) and b, TmrABPG (TmrAC416A, T61CBR56C) in the inward-facing wide (IFwide; PDB: 6RAN, left) and outward-facing open (OFopen; PDB: 6RAH, right) conformations. Approximate membrane position is indicated by the dashed grey line. For all simulations, TmrA is shown in blue with LD655 (orange) and TmrB in yellow with LD555 (green). c, AV simulations confirmed that donor-acceptor distances (RDA) remain within the FRET-sensitive range in both conformations, predicting measurable shifts in simulated FRET efficiencies (Esim). Cryo-EM structures of TmrAB reconstituted in lipid nanodiscs11 were used as templates. Structures were determined either in apo state (apo) or in presence of 3 mM ATP (turnover). Outward-facing open (OFopen) and outward-facing occluded (OFoccluded) structures were obtained via orthovanadate trapping (Vi) or by using the slow-turnover catalytic mutant TmrAE523QB (EQ).

Quality of TmrAB purification and fluorophore labeling.
a, SDS-PAGE analysis (10%, reducing conditions, Coomassie staining) of successive purification steps: M, molecular weight marker; L, cell lysate; B, Ni-NTA beads after incubation with lysate; FT, flow-through; W, wash; E, eluted TmrAB; BE, TmrAB after buffer exchange; C, concentrated TmrAB; CFT, concentrator flow-through; 1 and 2, first and second peaks eluted from size-exclusion chromatography (SEC). Only the second peak was used for subsequent FRET experiments. b, SEC (Superdex 200 increase 10/300 GL) confirming monodispersity of labeled TmrAB and efficient removal of free fluorophores. Representative chromatogram is shown for TmrABPG. c, ATP hydrolysis activity of purified wild-type TmrAB (60 nM TmrABwt) measured at 40 °C for 7 min. Released inorganic phosphate (Pi) was quantified using the Malachite Green assay. Data were fitted to a Michaelis-Menten model, yielding Km = 0.97 ± 0.28 mM and kcat = 2.57 ± 0.38 s−1. d–f, Analytical SEC (Superdex 200 increase 3.2/300) used to determine fluorophore labeling efficiencies for each variant: (d) TmrABNBD, LD555: ∼55%, LD655: ∼53%; (e) TmrABPG, LD555: ∼43%, LD655: ∼52%; and (f) TmrABPG_EQ, LD555: ∼42%, LD655: ∼52%.

FRET capabilities of labeled TmrAB variants.
a, Time-correlated single-photon counting histograms of LD555 (left) and LD655 (middle) measured under three conditions: free dye in buffer (black), LD555/LD655-labeled TmrABNBD (orange), and LD555/LD655-labeled TmrABPG (blue). Amplitude-weighted average fluorescence lifetimes are summarized in the table (right), confirming sufficient rotational freedom for reliable FRET measurements. b–d, Ensemble donor-exited emission spectra (550–700 nm, excitation 520 nm) of (b) TmrABNBD, (c) TmrABPG, and (d) the slow-turnover variant TmrABPG_EQ, stochastically labeled with LD555/LD655 and incubated with increasing ATP concentrations. Spectra are normalized to donor intensity in the apo state. ATP-dependent donor quenching and acceptor sensitization indicate that all variants retain FRET capability. e–g, Fractional fluorescence changes, (F-F₀)/F₀, where F is acceptor emission intensity and F₀ is the intensity in the apo state, plotted as a function of ATP concentration for (e) TmrABNBD, (f) TmrABPG, and (g) TmrABPG_EQ. Data were fitted with a hyperbolic binding model to determine apparent Kd, ATP values, consistent with ensemble FRET measurements of ATP binding.

ATP-induced conformational changes of TmrAB analyzed by smFRET.
a, Experimental setup. TmrABNBD (left) and TmrABPG (right) variants were labeled with LD555/LD655 and tethered to PEGylated coverslips via a biotinylated anti-TmrB nanobody (Nb9F10S63C). b, smFRET imaging. Samples were recorded using total internal reflection fluorescence (TIRF) microscopy with alternating laser excitation (ALEX; donor: 532 nm; acceptor: 640 nm). Emission was collected in two channels (donor: 498-620 nm; acceptor: 662-710 nm). Donor fluorescence (



Representative smFRET traces of TmrABNBD.
Representative single-molecule FRET (smFRET) traces of TmrABNBD were recorded (a) in the ATP-free state and (b, c) in the presence of 3 mM ATP. Hidden Markow modeling (HMM) was applied to classify traces into (b) static and (c) dynamic, based on the absence or presence of transitions between ATP-free and ATP-bound conformational states. Donor fluorescence intensity upon donor excitation is shown in green, acceptor fluorescence intensity upon donor excitation in orange, FRET efficiency (E) in black, and stoichiometry (S) in grey.

Representative smFRET traces of TmrABPG.
Representative single-molecule FRET (smFRET) traces of TmrABPG were recorded (a) in the ATP-free state and (b, c) in the presence of 3 mM ATP. Hidden Markow modeling (HMM) was applied to classify traces into (b) static and (c) dynamic, based on the absence or presence of transitions between ATP-free and ATP-bound conformational states. Donor fluorescence intensity upon donor excitation is shown in green, acceptor fluorescence intensity upon donor excitation in orange, FRET efficiency (E) in black, and stoichiometry (S) in grey.

ATP-dependent shifts in smFRET populations of TmrAB.
a,c, Increasing ATP concentrations gradually redistributed the population between apo and ATP-bound conformations for (a) TmrABNBD and (c) TmrABPG. FRET efficiency (E) histograms were fitted with two Gaussian populations corresponding to the ATP-free state (blue: defined from apo samples) and the ATP-bound state (orange; determined from fits at saturating ATP). Dotted vertical lines indicate the mean E values of each population. Relative proportion fractions, calculated from Gaussian areas, are summarized schematically in each panel. b,d, ATP-binding curves were obtained by plotting the fraction of molecules in the ATP-bound states as a function of ATP concentration for (b) TmrABNBD (reporting NBD dimerization) and (d) TmrABPG (reporting PG opening). Data were fitted with a Langmuir isotherm to determine the apparent dissociation constant Kd, ATP of each variant.

Identification of the outward-facing open (OFopen) conformation.
a–c, Three complementary approaches were employed to resolve OFopen state: (a) the slow-turnover variant TmrABPG_EQ, (b) imaging in Mg2+-free buffer supplemented with EDTA, and (c) stabilizing via reverse inhibition using high concentrations of peptide substrate. FRET efficiency (E) histograms were fitted with three Gaussian populations corresponding to the ATP-free state (blue), the ATP-bound state (orange), and the stabilized OFopen state (green). All three strategies revealed a distinct OFopen population. Dotted vertical lines indicate the mean E values of each population. Relative proportion fractions, calculated from Gaussian areas, are summarized schematically in each panel. d, Comparison of inter-residues distances. Distances (Å) between selected residues on the NBDs and PG of TmrAB were determined by multiple methods: smFRET values (this study) for detergent-solubilized TmrAB; cryo-EM distances (Cβ–Cβ) from nanodisc-reconstituted TmrAB (PDB 6RAH, 6RAN)11; accessible-volume (AV) simulation distances for nanodisc-reconstituted TmrAB (this study); and PELDOR/DEER distances from detergent-solubilized TmrAB15.

Conformational state distribution and catalytic cycle of TmrAB under active turnover.
Schematic of the TmrAB transport cycle summarizing major conformational states and their estimated population distributions under physiological ATP concentrations (3 mM, 40 °C). a, The inward-facing apo state (IFnarrow and IFwide; blue arc) accounts for ∼20% of molecules and is characterized by separated NBDs and a cytosol-accessible substrate-binding cavity. Substrate binding stabilizes the IFwide conformation11. Independent of substrate, ATP binding induces NBD dimerization and transition to the ATP-bound ensemble. b,c, Under substrate-bound turnover conditions, TmrAB proceeds via the (b) OFoccluded to (c) OFopen state in which the substrate release occurs. Under steady-state turnover, the ATP-bound ensemble rapidly interconverts between substrate-free OFoccluded and OFopen accounting for ∼25% of the ATP-bound population (green circle). These transitions occur faster than the ∼200 ms temporal resolution of standard smFRET measurement, resulting in an averaged signal under turnover conditions. OFoccluded likely serves as an obligate intermediate between IF and OFopen, preventing substrate backflow by maintaining a substrate-binding cavity occluded during the structural rearrangements of the PG and NBDs. Although a substrate-bound OFoccluded state has not been directly observed for TmrAB, its existence is supported by structures of the homodimeric type IV transporter BmrA46. Reduced ATP hydrolysis or substrate trans-inhibition enables trapping of the transporter in the OFopen. state. d,e, ATP hydrolysis and phosphate (Pi) release generate post-hydrolysis return states: (d) URasym and (e) URasym*. Subsequent ADP release restores the apo IF conformation, completing the transport cycle. Overall, the ATP-bound phase (b–e) represents ∼55% occupancy (orange arc) with an estimated dwell time of ∼310 ms, whereas the apo/ATP-rebinding phase (a) lasts ∼90 ms, yielding a total cycle time of ∼400 ms (kcat = 2.57 s⁻¹). TmrA is shown in blue, TmrB in yellow, substrate as a green diamond, and nucleotides as orange symbols. Dotted grey boxes indicate the approximate position of the NBD dimer interface.